Lisata Therapeutics Inc (LSTA)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current LSTA market cap is 20.52M. The company's latest EPS is USD -2.3184 and P/E is -1.01.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1M |
| Operating Income | -6.03M | -6.6M | -5.52M | -5.34M | -4.95M |
| Net Income | -5.37M | -5.4M | -5.04M | -4.93M | -4.61M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1M |
| Operating Income | -19.15M | -29.05M | -57.6M | -25.71M | -22.41M |
| Net Income | -8.15M | -27.47M | -54.23M | -20.84M | -19.99M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.69M | 48.24M | 42.57M | 38.2M | 35M |
| Total Liabilities | 6.8M | 5.5M | 4.58M | 4.76M | 5.69M |
| Total Equity | 47.89M | 42.74M | 38M | 33.44M | 29.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 36M | 97.01M | 73.03M | 54.69M | 35M |
| Total Liabilities | 3.76M | 5.01M | 6.71M | 6.8M | 5.69M |
| Total Equity | 32.24M | 92M | 66.32M | 47.89M | 29.32M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.03M | -7.03M | -12.31M | -14.83M | -19.36M |
| Investing | 10.1M | 6.44M | 18.15M | 11.84M | 13.23M |
| Financing | 385k | -142k | -110k | -110k | -206k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.82M | -22.25M | -21.17M | -20.03M | -19.36M |
| Investing | -7.28M | -54.9M | 28.91M | 10.1M | 13.23M |
| Financing | 18.58M | 85.28M | -224k | 385k | -206k |
| Market Cap | 20.52M |
| Price to Earnings Ratio | -1.01 |
| Price to Sales Ratio | 20.26 |
| Price to Cash Ratio | 1.25 |
| Price to Book Ratio | 0.69 |
| Dividend Yield | - |
| Shares Outstanding | 8.62M |
| Average Volume (1 week) | 7.6k |
| Average Volume (1 Month) | 15.66k |
| 52 Week Change | -23.23% |
| 52 Week High | 4.20 |
| 52 Week Low | 2.0717 |
| Spread (Intraday) | 0.32 (12.7%) |
| Company Name | Lisata Therapeutics Inc |
| Address |
651 n broad st suite 201 wilmington, delaware 19709 |
| Website | https://www.caladrius.com |
| Industry | insurance carriers, nec (6399) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
